Results 221 to 230 of about 71,938 (313)

Pamrevlumab did not meet its primary endpoint for non-ambulatory patients with Duchenne Muscular Dystrophy: the LELANTOS-1 trial

open access: green
Anne M. Connolly   +13 more
openalex   +1 more source

Longitudinal interaction between muscle impairments and gait pathology in growing children with Duchenne muscular dystrophy. [PDF]

open access: yesJ Neuroeng Rehabil
Vandekerckhove I   +7 more
europepmc   +1 more source

Circulating protein biomarkers identified in two independent clinical trial cohorts of glucocorticoid-naive Duchenne muscular dystrophy patients. [PDF]

open access: yesSci Rep
Ahmadiharchegani F   +18 more
europepmc   +1 more source

Implications for Cardiac Function Following Rescue of the Dystrophic Diaphragm in a Mouse Model of Duchenne Muscular Dystrophy [PDF]

open access: yes
A Asai   +37 more
core   +1 more source

Effect of sitting posture on development of scoliosis in Duchenne Muscular Dystrophy cases.

open access: green, 2018
Ramesh Pokharel   +8 more
openalex   +2 more sources

Serum protein biomarker signature of Duchenne muscular dystrophy. [PDF]

open access: yesEur J Transl Myol
Dowling P   +5 more
europepmc   +1 more source

Large-scale serum protein biomarkers discovery associated with function and clinical milestones in Duchenne muscular dystrophy. [PDF]

open access: yesNat Commun
Ikelaar NA   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy